Human chorionic gonadotropin-to-oocyte collection interval in a superovulation IVF program. A prospective study

Area of Science:

• Reproductive Endocrinology
• In Vitro Fertilization (IVF)

Background:

• Optimizing the timing of human chorionic gonadotropin (hCG) administration and oocyte retrieval is crucial for successful in vitro fertilization-embryo transfer (IVF-ET) cycles.
• Understanding the impact of the hCG-oocyte collection interval is essential for improving IVF-ET protocols.

Purpose of the Study:

• To determine if the interval between hCG administration and oocyte collection influences oocyte recovery rate, fertilization rate, and IVF-ET cycle outcomes.
• To analyze the effect of varying hCG-oocyte collection intervals on key IVF-ET parameters.

Main Methods:

• A retrospective analysis of 533 patients undergoing their first IVF-ET cycle.
• Data collected from King's Assisted Conception Unit between 1993 and 1995.
• Examination of oocyte recovery and fertilization rates across different hCG-oocyte collection intervals (33-41 hours).

Main Results:

• No statistically significant differences were observed in oocyte recovery rates across the studied hCG-oocyte collection intervals (33-41 hours).
• Fertilization rates and overall IVF-ET cycle outcomes remained consistent regardless of the hCG-oocyte collection interval.
• None of the 533 participants exhibited signs of premature ovulation before oocyte collection.

Conclusions:

• The duration of the hCG-oocyte collection interval (33-41 hours) does not appear to negatively affect IVF-ET cycle success.
• The findings do not support a correlation between longer intervals (beyond 36 hours) after hCG administration and increased ovulation rates.